Page last updated: 2024-10-26

dibucaine and Enterovirus Infections

dibucaine has been researched along with Enterovirus Infections in 1 studies

Dibucaine: A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)
cinchocaine : A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally only used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.

Enterovirus Infections: Diseases caused by ENTEROVIRUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tang, Q1
Xu, Z1
Jin, M1
Shu, T1
Chen, Y1
Feng, L1
Zhang, Q1
Lan, K1
Wu, S1
Zhou, HB1

Other Studies

1 other study available for dibucaine and Enterovirus Infections

ArticleYear
Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: In vitro, in vivo, and combination therapy study.
    European journal of medicinal chemistry, 2020, Sep-15, Volume: 202

    Topics: Animals; Antiviral Agents; Dibucaine; Dose-Response Relationship, Drug; Drug Therapy, Combination; E

2020